Collagen processing and its role in fibrosis

Cardiac Fibrosis and Heart Failure: Cause or Effect?

Volumn , Issue , 2015, Pages 261-278

  McCulloch, Christopher A ^a   Coelho, Nuno M ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Assembly; Collagen; Matrix; Matrix metalloproteinases; Phagocytosis; Proteases; Turnover

Indexed keywords

EID: 84943401731     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-319-17437-2_14     Document Type: Chapter

References (78)

1. Goldsmith EC, Bradshaw AD, Spinale FG (2013) Cellular mechanisms of tissue fibrosis. 2. Contributory pathways leading to myocardial fibrosis: Moving beyond collagen expression. Am J Physiol Cell Physiol 304: C393-C402
2. Maya L, Villarreal FJ (2009) Diagnostic approaches for diabetic cardiomyopathy and myocardial fibrosis. J Mol Cell Cardiol 48: 524-529
3. Srivastava PM, Calafiore P, Macisaac RJ, Patel SK, Thomas MC, Jerums G, Burrell LM(2008) Prevalence and predictors of cardiac hypertrophy and dysfunction in patients with Type 2 diabetes. Clin Sci (Lond) 114: 313-320
4. Heerebeek L van, Borbely A, Niessen HW, Bronzwaer JG, Velden J van der, Stienen GJ, Linke WA, Laarman GJ, Paulus WJ (2006) Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 113: 1966-1973
5. Heerebeek L van, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K, Ijsselmuiden AJ, Schalkwijk CG, Bronzwaer JG, Diamant M, Borbely A, Velden J van der, Stienen GJ, Laarman GJ, Niessen HW, Paulus WJ (2008) Diastolic stiffness of the failing diabetic heart: Importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 117: 43-51
6. Frustaci A, Kajstura J, Chimenti C, Jakoniuk I, Leri A, Maseri A, Nadal-Ginard B, Anversa P(2000) Myocardial cell death in human diabetes. Circ Res 87: 1123-1132
7. Asbun J, Villarreal FJ (2006) The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol 47: 693-700
8. Poirier P, Garneau C, Bogaty P, Nadeau A, Marois L, Brochu C, Gingras C, Fortin C, Jobin J, Dumesnil JG (2000) Impact of left ventricular diastolic dysfunction on maximal treadmill performance in normotensive subjects with well-controlled type 2 diabetes mellitus. Am J Cardiol 85: 473-477
9. Bhatia RS, Tu JV, Lee DS, Austin PC, Fang J, Haouzi A, Gong Y, Liu PP (2006) Outcome of heart failure with preserved ejection fraction in a population-based study. N Engl J Med355: 260-269
10. Owan TE, Hodge DO, Herges RM, Jacobsen SJ, Roger VL, Redfield MM (2006) Trends in prevalence and outcome of heart failure with preserved ejection fraction. N Engl J Med355: 251-259
11. Burlew BS, Weber KT (2002) Cardiac fibrosis as a cause of diastolic dysfunction. Herz27: 92-98
12. Howlett JG, McKelvie RS, Arnold JM, Costigan J, Dorian P, Ducharme A, Estrella-Holder E, Ezekowitz JA, Giannetti N, Haddad H, Heckman GA, Herd AM, Isaac D, Jong P, Kouz S, Liu P, Mann E, Moe GW, Tsuyuki RT, Ross HJ, White M (2009) Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: Diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials. Can J Cardiol 25: 85-105
13. Brilla CG, Maisch B, Rupp H, Funck R, Zhou G, Weber KT (1995) Pharmacological modulation of cardiac fibroblast function. Herz 20: 127-134
14. Brilla CG, Maisch B, Weber KT (1992) Myocardial collagen matrix remodelling in arterial hypertension. Eur Heart J 13(Suppl D): 24-32
15. Weber KT, Sun Y, Tyagi SC, Cleutjens JP (1994) Collagen network of the myocardium: Function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 26: 279-292
16. Perez-Tamayo R (1978) Pathology of collagen degradation. A review. Am J Pathol 92: 508-566
17. Covell JW (1990) Cardiac myocyte connective tissue interactions in health and disease, vol 13. Pp. 99-112
18. Carver W, Nagpal ML, Nachtigal M, Borg TK, Terracio L (1991) Collagen expression in mechanically stimulated cardiac fibroblasts. Circ Res 69: 116-122
19. Yamazaki T, Komuro I, Yazaki Y (1998) Signalling pathways for cardiac hypertrophy. Cell Signal 10: 693-698
20. Olson EN, Srivastava D (1996) Molecular pathways controlling heart development. Science272: 671-676
21. Sun Y, Weber KT (1996) Cells expressing angiotensin II receptors in fibrous tissue of rat heart. Cardiovasc Res 31: 518-525
22. Butt RP, Laurent GJ, Bishop JE (1995) Mechanical load and polypeptide growth factors stimulate cardiac fibroblast activity. Ann N Y Acad Sci 752: 387-393
23. Gonzalez A, Lopez B, Ravassa S, Beaumont J, Arias T, Hermida N, Zudaire A, Diez J (2009)Biochemical markers of myocardial remodelling in hypertensive heart disease. Cardiovasc Res 81: 509-518
24. Wilke A, Funck R, Rupp H, Brilla CG (1996) Effect of the renin-angiotensin-aldosterone system on the cardiac interstitium in heart failure. Basic Res Cardiol 91(Suppl 2): 79-84
25. Keating MT, Sanguinetti MC (1996) Molecular genetic insights into cardiovascular disease. Science 272: 681-685
26. Singh VP, Baker KM, Kumar R (2008) Activation of the intracellular renin-angiotensin system in cardiac fibroblasts by high glucose: Role in extracellular matrix production. Am J Physiol Heart Circ Physiol 294: H1675-H1684
27. Aragno M, Mastrocola R, Alloatti G, Vercellinatto I, Bardini P, Geuna S, Catalano MG, Danni O, Boccuzzi G (2008) Oxidative stress triggers cardiac fibrosis in the heart of diabetic rats. Endocrinology 149: 380-388
28. Tsujino T, Kawasaki D, Masuyama T (2006) Left ventricular diastolic dysfunction in diabetic patients: Pathophysiology and therapeutic implications. Am J Cardiovasc Drugs 6: 219-230
29. Herrmann KL, McCulloch AD, Omens JH (2003) Glycated collagen cross-linking alters cardiac mechanics in volume-overload hypertrophy. Am J Physiol Heart Circ Physiol284: H1277-H1284
30. Berg TJ, Snorgaard O, Faber J, Torjesen PA, Hildebrandt P, Mehlsen J, Hanssen KF (1999)Serum levels of advanced glycation end products are associated with left ventricular diastolic function in patients with type 1 diabetes. Diabetes Care 22: 1186-1190
31. Adeghate E (2004) Molecular and cellular basis of the aetiology and management of diabetic cardiomyopathy: A short review. Mol Cell Biochem 261: 187-191
32. Zieman S, Kass D (2004) Advanced glycation end product cross-linking: Pathophysiologic role and therapeutic target in cardiovascular disease. Congest Heart Fail 10: 144-149; quiz 150-141 (Greenwich, Conn)
33. Casis O, Echevarria E (2004) Diabetic cardiomyopathy: Electromechanical cellular alterations. Curr Vasc Pharmacol 2: 237-248
34. Asif M, Egan J, Vasan S, Jyothirmayi GN, Masurekar MR, Lopez S, Williams C, Torres RL, Wagle D, Ulrich P, Cerami A, Brines M, Regan TJ (2000) An advanced glycation endproduct cross-link breaker can reverse age-related increases in myocardial stiffness. Proc Natl Acad Sci U S A 97: 2809-2813
35. Grove D, Zak R, Nair KG, Aschenbrenner V (1969) Biochemical correlates of cardiac hypertrophy. Iv. Observations on the cellular organization of growth during myocardial hypertrophy in the rat. Circ Res 25: 473-485
36. Eghbali M (1992) Cardiac fibroblasts: Function, regulation of gene expression, and phenotypic modulation. Basic Res Cardiol 87(Suppl 2): 183-189
37. Khan R, Sheppard R (2006) Fibrosis in heart disease: Understanding the role of transforming growth factor-beta in cardiomyopathy, valvular disease and arrhythmia. Immunology118: 10-24
38. Kuwahara F, Kai H, Tokuda K, Kai M, Takeshita A, Egashira K, Imaizumi T (2002) Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 106: 130-135
39. Sadoshima J, Izumo S (1997) The cellular and molecular response of cardiac myocytes to mechanical stress. Annu Rev Physiol 59: 551-571
40. Campbell SE, Katwa LC (1997) Angiotensin II stimulated expression of transforming growth factor-beta1 in cardiac fibroblasts and myofibroblasts. J Mol Cell Cardiol 29: 1947-1958
41. Lee AA, Dillmann WH, McCulloch AD, Villarreal FJ (1995) Angiotensin II stimulates the autocrine production of transforming growth factor-beta 1 in adult rat cardiac fibroblasts. J Mol Cell Cardiol 27: 2347-2357
42. Kim NN, Villarreal FJ, Printz MP, Lee AA, Dillmann WH (1995) Trophic effects of angiotensin II on neonatal rat cardiac myocytes are mediated by cardiac fibroblasts. Am J Physiol269: E426-E437
43. Burgess ML, Carver WE, Terracio L, Wilson SP, Wilson MA, Borg TK (1994) Integrin-mediated collagen gel contraction by cardiac fibroblasts. Effects of angiotensin II. Circ Res74: 291-298
44. Miragoli M, Gaudesius G, Rohr S (2006) Electrotonic modulation of cardiac impulse conduction by myofibroblasts. Circ Res 98: 801-810
45. Miragoli M, Salvarani N, Rohr S (2007) Myofibroblasts induce ectopic activity in cardiac tissue. Circ Res 101: 755-758
46. Zlochiver S, Munoz V, Vikstrom KL, Taffet SM, Berenfeld O, Jalife J (2008) Electrotonic myofibroblast-to-myocyte coupling increases propensity to reentrant arrhythmias in twodimensional cardiac monolayers. Biophys J 95: 4469-4480
47. Askar SF, Ramkisoensing AA, Schalij MJ, Bingen BO, Swildens J, Laarse A van der, Atsma DE, Vries AA de, Ypey DL, Pijnappels DA (2011) Antiproliferative treatment of myofibroblasts prevents arrhythmias in vitro by limiting myofibroblast-induced depolarization. Car-diovasc Res 90: 295-304
48. Porter KE, Turner NA (2009) Cardiac fibroblasts: At the heart of myocardial remodeling. Pharmacol Ther 123: 255-278
49. Bradshaw AD, Baicu CF, Rentz TJ, Laer AO Van, Bonnema DD, Zile MR (2010) Age-dependent alterations in fibrillar collagen content and myocardial diastolic function: Role of SPARC in post-synthetic procollagen processing. Am J Physiol Heart Circ Physiol 298: H614-H622
50. Bradshaw AD (2009) The role of SPARC in extracellular matrix assembly. J Cell Commun Signal 3: 239-246
51. Bradshaw AD, Baicu CF, Rentz TJ, Laer AO Van, Boggs J, Lacy JM, Zile MR (2009) Pressure overload-induced alterations in fibrillar collagen content and myocardial diastolic function: Role of secreted protein acidic and rich in cysteine (SPARC) in post-synthetic procollagen processing. Circulation 119: 269-280
52. Lenga Y, Koh A, Perera AS, McCulloch CA, Sodek J, Zohar R (2008) Osteopontin expression is required for myofibroblast differentiation. Circ Res 102: 319-327
53. Leslie KO, Taatjes DJ, Schwarz J, vonTurkovich M, Low RB (1991) Cardiac myofibroblasts express alpha smooth muscle actin during right ventricular pressure overload in the rabbit. Am J Pathol 139: 207-216
54. Goldsmith EC, Bradshaw AD, Zile MR, Spinale FG (2014) Myocardial fibroblast-matrix interactions and potential therapeutic targets. J Mol Cell Cardiol 70C: 92-99
55. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G (1993) Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 122: 103-111
56. Arora PD, Narani N, McCulloch CA (1999) The compliance of collagen gels regulates transforming growth factor-beta induction of alpha-smooth muscle actin in fibroblasts. Am J Pathol 154: 871-882
57. Gabbiani G (2003) The myofibroblast in wound healing and fibrocontractive diseases. J Pathol 200: 500-503
58. Tomasek JJ, Gabbiani G, Hinz B, Chaponnier C, Brown RA (2002) Myofibroblasts and mechano-regulation of connective tissue remodelling. Nat Rev Mol Cell Biol 3: 349-363
59. Shi-Wen X, Renzoni EA, Kennedy L, Howat S, Chen Y, Pearson JD, Bou-Gharios G, Dash-wood MR, Bois RM du, Black CM, Denton CP, Abraham DJ, Leask A (2007) Endogenous endothelin-1 signaling contributes to type I collagen and CCN2 overexpression in fibrotic fibroblasts. Matrix Biol 26: 625-632
60. Kitamura M, Shimizu M, Ino H, Okeie K, Yamaguchi M, Funjno N, Mabuchi H, Nakanishi I(2001) Collagen remodeling and cardiac dysfunction in patients with hypertrophic cardiomyopathy: The significance of type III and VI collagens. Clin Cardiol 24: 325-329
61. Pittet P, Lee K, Kulik AJ, Meister JJ, Hinz B (2008) Fibrogenic fibroblasts increase intercellular adhesion strength by reinforcing individual OB-cadherin bonds. J Cell Sci 121: 877-886
62. Hinz B, Pittet P, Smith-Clerc J, Chaponnier C, Meister JJ (2004) Myofibroblast development is characterized by specific cell-cell adherens junctions. Mol Biol Cell 15: 4310-4320
63. Madsen DH, Leonard D, Masedunskas A, Moyer A, Jurgensen HJ, Peters DE, Amornphi-moltham P, Selvaraj A, Yamada SS, Brenner DA, Burgdorf S, Engelholm LH, Behrendt N, Holmbeck K, Weigert R, Bugge TH (2013) M2-like macrophages are responsible for collagen degradation through a mannose receptor-mediated pathway. J Cell Biol 202: 951-966
64. Everts V, Zee E van der, Creemers L, Beertsen W (1996) Phagocytosis and intracellular digestion of collagen, its role in turnover and remodelling. Histochem J 28: 229-245
65. Olazabal IM, Caron E, May RC, Schilling K, Knecht DA, Machesky LM (2002) Rho-kinase and myosin-II control phagocytic cup formation during CR, but not FcgammaR, phagocytosis. Curr Biol 12: 1413-1418
66. Rougerie P, Miskolci V, Cox D. Generation of membrane structures during phagocytosis and chemotaxis of macrophages: Role and regulation of the actin cytoskeleton. Immunol Rev256: 222-239
67. Arora PD, Conti MA, Ravid S, Sacks DB, Kapus A, Adelstein RS, Bresnick AR, McCulloch CA (2008) Rap1 activation in collagen phagocytosis is dependent on nonmuscle myosin II-A. Mol Biol Cell 19: 5032-5046
68. Arora PD, Glogauer M, Kapus A, Kwiatkowski DJ, McCulloch CA (2004) Gelsolin mediates collagen phagocytosis through a rac-dependent step. Mol Biol Cell 15: 588-599
69. Melcher AH, Chan J (1981) Phagocytosis and digestion of collagen by gingival fibroblasts in vivo: A study of serial sections. J Ultrastruct Res 77: 1-36
70. Meshel AS, Wei Q, Adelstein RS, Sheetz MP (2005) Basic mechanism of three-dimensional collagen fibre transport by fibroblasts. Nat Cell Biol 7: 157-164
71. Hay ED (1981) Extracellular matrix. J Cell Biol 91: 205S-223s
72. Visse R, Nagase H (2003) Matrix metalloproteinases and tissue inhibitors of metalloproteinases: Structure, function, and biochemistry. Circ Res 92: 827-839
73. Tam EM, Moore TR, Butler GS, Overall CM (2004) Characterization of the distinct collagen binding, helicase and cleavage mechanisms of matrix metalloproteinase 2 and 14 (gelatinase A and MT1-MMP): The differential roles of the MMP hemopexin c domains and the MMP-2 fibronectin type II modules in collagen triple helicase activities. J Biol Chem 279: 43336-43344
74. Egeblad M, Werb Z (2002) New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2: 161-174
75. Lee H, Overall CM, McCulloch CA, Sodek J (2006) A critical role for the membrane-type 1 matrix metalloproteinase in collagen phagocytosis. Mol Biol Cell 17: 4812-4826
76. Arora PD, Manolson MF, Downey GP, Sodek J, McCulloch CA (2000) A novel model system for characterization of phagosomal maturation, acidification, and intracellular collagen degradation in fibroblasts. J Biol Chem 275: 35432-35441
77. Yuen A, Laschinger C, Talior I, Lee W, Chan M, Birek J, Young EW, Sivagurunathan K, Won E, Simmons CA, McCulloch CA Methylglyoxal-modified collagen promotes myofibroblast differentiation. Matrix Biol 29: 537-548
78. Chong SA, Lee W, Arora PD, Laschinger C, Young EW, Simmons CA, Manolson M, Sodek J, McCulloch CA (2007) Methylglyoxal inhibits the binding step of collagen phagocytosis. J Biol Chem 282: 8510-8520